John Grous, M.D.

Vice President, Medical Affairs (Consultant)

John Grous, M.D. is a board-certified medical oncologist with extensive experience in cancer therapeutic drug development.

After eight years of an academic oncology practice in Boston serving as a Principal Investigator for Neupogen (Amgen) and other hematopoietic growth factors, Dr. Grous has served in the biotech and pharmaceutical industry from medical director to vice-president with several small companies.

His last role was with AstraZeneca and part of the NDA team and accelerated FDA approval for the epidermal growth factor receptor antagonist, Iressa (gefitinb).